A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Jack Gilleland
| Share Statistics | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $10.0 | $286.3 | 6% |
|
| Shares Out (Mil) | na | 54.2 | na |
|
| Institutional Ownership | 94.5% | 92.8% | 65% |
|
| Float (Mil) | 1.6 | 39.7 | 4% |
|
| Beta | na | 0.94 | na |
|
| Avg Daily Volume (000s) | 25 | 534 | 22% |
|
| Price Change (52-week) |
(30.2%) | 58.7% | 23% |
|
| Growth | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 13.6% | na |
|
| Net Income (5yr) | (49.7%) | (10.1%) | 7% |
|
| EPS (5yr) | na | 16.0% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.6%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 2 | 2 | 2 | |
| Current EPS | ($1.760) | ($7.170) | ($3.185) | |
| Month Ago EPS | ($1.685) | ($6.880) | ($2.910) | |
| # Rev Up | 0 | 1 | 0 | |
| # Rev Down | 1 | 0 | 1 | |
| Three Months Ago EPS | ($1.320) | ($5.850) | ($3.900) | |
| Year/Year Chg | na | (51.5%) | (94.0%) | |
| Financials | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $37 | na |
|
| Net Income (TTM) (Mil) | ($19) | ($43) | 24% |
|
| EPS (TTM) | na | ($1.400) | na |
|
| Operating Cash Flow (TTM) (Mil) | ($15) | ($31) | 17% |
|
| Net Cash Flow (TTM) (Mil) | $2 | $2 | 48% |
|
| Long-Term Debt (Q1) (Mil) | $1 | $4 | 18% |
|
| Enterprise Value (Q1) (Mil) | $1 | $160 | 4% |
|
| Valuation | QNRX | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 2.77 | na |
|
| P/E | na | 19.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.0 | na |
|
| Ratios | QNRX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 64.2% | na |
|
| Net Margin | na | (75.9%) | na |
|
| ROA | (178.8%) | (47.3%) | 2% |
|
| ROE | (575.7%) | (55.0%) | 1% |
|
| Liabilities to Assets | 67.1% | 29.6% | 63% |
|
| F-Score | 1 | 2 | na |
|
Quoin Pharmaceuticals, Ltd. did not pass any screens on 8/20/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
